Employees Retirement System of Texas’s Lifecore Biomedical LFCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-170,400
Closed -$1.7M 541
2022
Q2
$1.7M Buy
170,400
+32,500
+24% +$322K 0.02% 538
2022
Q1
$1.6M Buy
137,900
+52,500
+61% +$585K 0.02% 600
2021
Q4
$948K Hold
85,400
0.01% 672
2021
Q3
$787K Buy
+85,400
New +$929K 0.01% 717

Other funds holding LFCR

Employees Retirement System of Texas's LFCR Position: Q3 2022 in Review

Employees Retirement System of Texas sold out of Lifecore Biomedical (LFCR) in Q3 2022, closing a stake of 170,400 shares — an estimated $1.7M sold.

Employees Retirement System of Texas first reported a position in LFCR in Q3 2021 and held it in 4 quarters. The position peaked at $1.7M in Q2 2022. 86 funds tracked by Wall St. Rank hold LFCR as of Q3 2022.

  • Employees Retirement System of Texas reported no remaining Lifecore Biomedical position as of Q3 2022 after selling out during the quarter.
  • Employees Retirement System of Texas sold 170,400 Lifecore Biomedical shares in Q3 2022, an estimated $1.7M.
  • Employees Retirement System of Texas first reported a position in Lifecore Biomedical in Q3 2021 and held it in 4 quarters.
  • Employees Retirement System of Texas's Lifecore Biomedical position peaked at $1.7M in Q2 2022.
  • 86 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2022.

Based on Employees Retirement System of Texas's 13F filing for Q3 2022, filed 10 Nov 2022.